SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001608901-20-000002
Filing Date
2020-02-04
Accepted
2020-02-04 11:45:53
Documents
1
Period of Report
2020-02-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 2985
  Complete submission text file 0001608901-20-000002.txt   4463
Mailing Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA N, SUITE 270 FORT LEE NJ 07024 201-464-2677
IMMUNE PHARMACEUTICALS INC (Issuer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 605 THIRD AVENUE, 34TH FLOOR NEW YORK NY 10158
Business Address
Fiorino Anthony S. (Reporting) CIK: 0001608901 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36602 | Film No.: 20571281